Stocks
Arrowhead Pharmaceuticals (ARWR) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 36.4 | -46.4 | -46.3 | -19.7 | -14.8 | -6.43 | ||
| Changes by years, y/y, % | -223% | -227% | 0% | -58% | -25% | -13.0% | |||
Arrowhead Pharmaceuticals. EV/EBITDA
Arrowhead Pharmaceuticals. EV/EBITDA, changes, %
Arrowhead Pharmaceuticals (ARWR) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -20.8 | -14.3 | -11.9 | -7.75 | -6.39 | -6.43 | |
| Changes by years, y/y, % | -9% | -24% | -53% | -53% | -69% | |||
| Changes by quarters, q/q, % | +27% | -31% | -17% | -35% | -18% | |||
